drugset / Trial / NCT04566757

Safety and Efficacy of Human Umbilical Cord Blood Plasma Infusion for Age-Related Cognitive Decline

NCT04566757 ↗

Phase 1 Unknown 12 enrolled American Academy of Regenerative Medicine
NaSingle-groupOpen-labelTreatment

Summary

This study is designed to investigate the safety of Umbilical Cord Blood Plasma infusions in elderly adults regardless of gender, with age-related cognitive decline. Human clinical data of the use of young plasma appear to show beneficial cognitive effects.

Timeline

Start
2021-03-01
Primary completion
2021-12-01
Completion
2022-06-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Umbilical Cord Blood Plasma Unknown 50 ml Intravenous

Indications